LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Cancer Focus TegMine specializes in antibody-based therapies targeting glycoproteins linked to aggressive solid cancers, indicating a strong potential for collaboration with pharmaceutical companies seeking next-generation oncology treatments.

Collaborative Expansion Recent partnership with Boehringer Ingelheim to develop antibody-drug conjugates suggests an openness to strategic alliances, providing opportunities for co-development and licensing negotiations.

Technological Edge Utilizing proprietary platforms like TegMiner™ for epitope discovery positions TegMine as a cutting-edge partner in custom antibody development, appealing to companies looking for advanced biotech solutions.

Growth and Funding With revenue between $1M and $10M and a focus on innovative therapies, TegMine is an attractive prospect for investors and partners interested in early-stage biotech growth with high potential in targeted cancer treatments.

Market Trends Alignment Operating within the rapidly expanding biotech and immunotherapy sectors, TegMine's focus on targeted cancer drugs aligns with current market trends favoring precision medicine, offering potential for strategic positioning and market entry.

TegMine Therapeutics, Inc. Tech Stack

TegMine Therapeutics, Inc. uses 7 technology products and services including Google Workspace, Apple iCloud Mail, Font Awesome, and more. Explore TegMine Therapeutics, Inc.'s tech stack below.

  • Google Workspace
    Email
  • Apple iCloud Mail
    Email
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • DreamHost
    Web Hosting
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

TegMine Therapeutics, Inc.'s Email Address Formats

TegMine Therapeutics, Inc. uses at least 1 format(s):
TegMine Therapeutics, Inc. Email FormatsExamplePercentage
First@tegminetx.comJohn@tegminetx.com
50%
First@tegminetx.comJohn@tegminetx.com
50%

Frequently Asked Questions

Where is TegMine Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconTegMine Therapeutics, Inc.'s main headquarters is located at South San Francisco, California 94080 United States. The company has employees across 1 continents, including North America.

What is TegMine Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconTegMine Therapeutics, Inc.'s official website is tegminetx.com and has social profiles on LinkedInCrunchbase.

What is TegMine Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconTegMine Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does TegMine Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, TegMine Therapeutics, Inc. has approximately 9 employees across 1 continents, including North America. Key team members include Director: J. H.. Explore TegMine Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does TegMine Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconTegMine Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does TegMine Therapeutics, Inc. use?

Minus sign iconPlus sign iconTegMine Therapeutics, Inc.'s tech stack includes Google WorkspaceApple iCloud MailFont AwesomejQueryDreamHostApacheApache HTTP Server.

What is TegMine Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconTegMine Therapeutics, Inc.'s email format typically follows the pattern of First@tegminetx.com. Find more TegMine Therapeutics, Inc. email formats with LeadIQ.

TegMine Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

At Tegmine we target glycoproteins, which are a hallmark of numerous solid cancers and drive aggressive disease. We’ve engineered a system to generate revolutionary new antibody-based therapies for cancer which dramatically increase efficacy while reducing toxic side effects. Our proprietary TegMiner™ platform enables the discovery of unique cancer epitopes and allows us to develop these life-changing new antibodies for patients with unmet needs.

Section iconCompany Overview

Headquarters
South San Francisco, California 94080 United States
Website
tegminetx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    TegMine Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    TegMine Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. H.
    Director
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.